Company Overview
- Headquarters
- 55 Network Drive, Burlington MA
- Website
- dyax.com
- as****@dyax.com
- Phone
- (617) 225-2500
- Employees
- 62
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Dyax
Dyax was a biotechnology company headquartered in Burlington, Massachusetts. The company employed 62 people and generated approximately $50 million in annual revenue. Dyax focused on the development and commercialization of novel therapies for rare and serious diseases. Their product portfolio included treatments for hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling. Dyax was known for its innovative approach to drug development, utilizing a proprietary platform technology to create targeted therapies. Their commitment to patient care and scientific excellence positioned them as a leader in the field of HAE treatment. For further information, please visit Shire's LinkedIn page at www.linkedin.com/company/shire or www.shire.com.
Companies Similar to Dyax
Analyze industry trends and opportunities by examining competitors and companies comparable to Dyax, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |